Rite Aid Corp: (NYSE: RAD)

$3.13

-0.01 (-0.16%)

Volume 15,280,926

Jun 19 02:48 PM ET

Zacks Rank: 2-Buy

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		3.09 - 3.17
	
		52wk Low - High
		0.95 - 3.21
	
		Previous Close
		3.13
	
		Avg. Volume
		19,705,996
	
		Industry
		RETAIL-DRUG STR
	
		Market Cap
		2.84 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		2.53
	
		P/E (F1)
		18.15
	
		Current Year Est.
		0.17
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		2
Buy

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		80 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 04/30/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            P/E (F1)
                            18.15
                        
                            PEG Ratio
                            NA
                        
                            Current Year Est.
                            0.17
                        
                            Current Quarter Estimate
                            0.09
                        
                            Most Accurate Estimate
                            0.09
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            06-20-2013
                        
                            EPS Last Year
                            0.24
                        
                            Expected Earnings Growth
                            NA
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Rite Aid Corporation is a retail drugstore chain in the United States  serving customers in numerous states across the country and in the District of Columbia. It operates stores in the majority of the major U.S. metropolitan markets. The company operates in two business segments: the retail drug segment and the pharmacy benefit management segment.   
Full RAD Company Report

 Analyst Report on RAD

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
RAD Chart  by YCharts

Earnings Estimates

	Current Qtr (05/2013)	Next Qtr (08/2013)	Current Year (02/2014)	Next Year (02/2015)
Average Estimate	0.09	-0.01	0.17	0.23
Number of Estimates	4	4	4	2
Low Estimate	0.08	-0.03	0.15	0.22
High Estimate	0.09	0.02	0.20	NA
Year Ago EPS	0.01	-0.05	0.24	0.17
EPS Growth	775.00%	85.00%	-28.12%	36.23%

More RAD Estimates

Average Earnings Estimates for RAD

EPS Growth for RAD

Industry Analysis

Name	Symbol	Previous Close
RITE AID CORP	RAD	3.13
GNC HOLDINGS	GNC	47.93
HERBALIFE LTD	HLF	49.55
AMERISOURCEBRGN	ABC	55.86
BIOSCRIP INC	BIOS	15.98
CARDINAL HEALTH	CAH	48.76
CVS CAREMARK CP	CVS	59.91
MCKESSON CORP	MCK	114.62
PHARMERICA CORP	PMC	16.20
WALGREEN CO	WAG	50.90

Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR

COMPARE TICKER vs. Its Peers

Zacks Commentary

Rite Aid Continues Debt Refinancing

Jun 18, 2013

BioScrip Grows with CarePoint Buyout

Jun 18, 2013

Will Rite Aid Beat Earnings Est. Again?

Jun 17, 2013

WAG-DEA Settlement to Hurt 3Q Earnings

Jun 12, 2013

Rite Aid to Refinance Debt

Jun 10, 2013

Weak May Comps for Rite Aid

Jun 07, 2013

Gap's May Comps Reveal Upward Trend

Jun 07, 2013

WAG 3Q13 Sales Miss; Strong May

Jun 06, 2013

More RAD Zacks Commentary

Financials

EPS TTM	0.24
Sales	25,392
Net Income	118
Price/Earnings	13.04
Price/Book	NA
Price/Cash Flow	4.47
Price/Sales	0.11

More RAD Financials

News

Earnings Scheduled for June 20, 2013 - Benzinga

Jun 19, 2013

Rite Aid Continues Debt Refinancing - Zacks.Com

Jun 19, 2013

Rite Aid Introduces wellness65 for Seniors - Businesswire

Jun 19, 2013

5 Stocks Poised to Pop on Bullish Earnings - TheStreet.com

Jun 18, 2013

Can Rite Aid Meet These Numbers? - TheMotleyFool

Jun 18, 2013

Is Rite Aid Really Back? - TheMotleyFool

Jun 18, 2013

Is Rite Aid???s Rally Sustainable? - TheMotleyFool

Jun 18, 2013

J.C. Penney Looks Like a Long-Term Bankruptcy Candidate - TheMotleyFool

Jun 18, 2013

See All News Stories on RAD

Broker Recommendations

Current ABR	2.67
ABR (Last Week)	2.67
# of recs in ABR	3
Average Target Price	3.30
Industry Rank by ABR	80 out of 265
Rank in Industry	1 out of 11

More RAD Broker Recommendations

Day Low - High	3.09 - 3.17
52wk Low - High	0.95 - 3.21
Previous Close	3.13
Avg. Volume	19,705,996
Industry	RETAIL-DRUG STR
Market Cap	2.84 B
Div - Yield	0.00 - 0.00
Beta	2.53
P/E (F1)	18.15
Current Year Est.	0.17
Quarterly Earnings ESP	0.00%

P/E (F1)	18.15
PEG Ratio	NA
Current Year Est.	0.17
Current Quarter Estimate	0.09
Most Accurate Estimate	0.09
Earnings ESP	0.00%
Next Earnings Report Date	06-20-2013
EPS Last Year	0.24
Expected Earnings Growth	NA

Username: Password:

Remember me [?]

Rite Aid Corp: (NYSE: RAD)

$3.13

-0.01 (-0.16%)

Volume 15,280,926

Jun 19 02:48 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Retail-Wholesale>> Industry:RETAIL-DRUG STR

Zacks Commentary

Financials

News

Broker Recommendations